Matching slides 78,129
Current window 21,361-21,390
Pages 2,605
Rows per page 30
Component: Chartclear collectionreset all

Component

21,361-21,390 of 78,129

filter-aware
14
Includes a testimonial quote from a US KOL.Aeglea BioTherapeutics | Mergers and Acquisitions Presentation Deck | 50 slides · Aeglea BioTherapeutics
Deck Investment bank 2 hits
18
The slide uses a structural model of the protein complex and two dose-response curves to demonstrate efficacy and selectivity.Aeglea BioTherapeutics | Mergers and Acquisitions Presentation Deck | 50 slides · Aeglea BioTherapeutics
Deck Investment bank 2 hits
22
The slide uses a visual timeline/comparison to contrast the high injection frequency of the competitor with the lower frequency of SPY001.Aeglea BioTherapeutics | Mergers and Acquisitions Presentation Deck | 50 slides · Aeglea BioTherapeutics
Deck Investment bank 2 hits
32
Includes two charts: a dose-response curve and a scatter plot of potency vs. binding specificity.Aeglea BioTherapeutics | Mergers and Acquisitions Presentation Deck | 50 slides · Aeglea BioTherapeutics
Deck Investment bank 2 hits
43
The slide uses a comparative bar chart structure to show the delta in efficacy when using a companion diagnostic (CDx).Aeglea BioTherapeutics | Mergers and Acquisitions Presentation Deck | 50 slides · Aeglea BioTherapeutics
Deck Investment bank 2 hits
20
The slide uses donut charts to represent revenue composition and growth.Alkermes | Investor Presentation Deck | 56 slides · Alkermes
Conference presentation Investor relations Beat · Evidence & ProofLoop · Mece Breakdown2 hits
21
Uses a before-after comparison of drug development stages (Gantt-style pipeline).Alkermes | Investor Presentation Deck | 56 slides · Alkermes
Conference presentation Investor relations 2 hits
10
The slide uses a split layout with stacked bar charts on the left and numbered key takeaways on the right.Allego | Results Presentation Deck | 16 slides · Allego
Conference presentation Investor relations Beat · DesireLoop · Cost Of Inaction2 hits
11
The slide uses a split layout with charts on the left and key takeaways on the right.Allego | Results Presentation Deck | 16 slides · Allego
Conference presentation Investor relations Beat · ActionLoop · Quick Win Big Bet2 hits
12
The slide uses a split layout with charts on the left and key takeaways on the right.Allego | Results Presentation Deck | 16 slides · Allego
Conference presentation Investor relations Beat · ActionLoop · Quick Win Big Bet2 hits
08
The slide uses a three-column layout for clinical data and a footer for publication logos.argenx SE | Investor Presentation Deck | 22 slides · argenx
Conference presentation Investor relations Beat · Key Takeaways2 hits
15
The slide combines immunofluorescence microscopy (left) with physiological data (right) to demonstrate the mechanism of action and therapeutic efficacy.argenx SE | Investor Presentation Deck | 22 slides · argenx
Conference presentation Investor relations Beat · RoadmapLoop · Quick Win Big Bet2 hits
34
The slide uses two line charts to demonstrate improved vehicle dynamics and powertrain software tuning.Aston Martin Lagonda | Investor Day Presentation Deck | 66 slides · Aston Martin
Conference presentation Investor relations Beat · Product2 hits
62
The slide highlights the strategic pivot from internal combustion engines to battery electric vehicles.Aston Martin Lagonda | Investor Day Presentation Deck | 66 slides · Aston Martin
Conference presentation Investor relations Beat · Financials2 hits
13
Kaplan-Meier survival curves showing primary (2020) and updated (2023) analysis results.AstraZeneca | Investor Event Presentation Deck | 52 slides · AstraZeneca
Conference presentation Investor relations Beat · NeedLoop · Cost Of Inaction2 hits
23
Includes clinical trial abbreviations and definitions in the footer.AstraZeneca | Investor Event Presentation Deck | 52 slides · AstraZeneca
Conference presentation Investor relations Beat · SatisfactionLoop · Before After2 hits
26
Includes spider plot (target lesion change over time) and waterfall plot (best percentage change).AstraZeneca | Investor Event Presentation Deck | 52 slides · AstraZeneca
Conference presentation Investor relations Beat · Action2 hits
32
Clinical trial data presentation showing PFS outcomes for Arm 1 (chemo + bev) vs Arm 3 (chemo + bev + durvalumab + olaparib).AstraZeneca | Investor Event Presentation Deck | 52 slides · AstraZeneca
Conference presentation Investor relations Beat · Action2 hits
33
Clinical trial data presentation using Kaplan-Meier plots with associated risk tables and hazard ratios.AstraZeneca | Investor Event Presentation Deck | 52 slides · AstraZeneca
Conference presentation Investor relations Beat · Action2 hits
44
The slide uses a Kaplan-Meier curve for PFS and a forest plot for safety odds ratios.AstraZeneca | Investor Event Presentation Deck | 52 slides · AstraZeneca
Conference presentation Investor relations Beat · Action2 hits
50
Kaplan-Meier survival curves showing DFS probability over time from randomisation.AstraZeneca | Investor Event Presentation Deck | 52 slides · AstraZeneca
Conference presentation Investor relations Beat · Action2 hits
52
The slide uses bar charts to compare clinical trial data against historical SoC benchmarks. Right chart excludes pancreatic cohort due to small sample size.AstraZeneca | Investor Event Presentation Deck | 52 slides · AstraZeneca
Conference presentation Investor relations Beat · Action2 hits
15
Azek | Results Presentation Deck | 19 slidesAzek | Results Presentation Deck | 19 slides · The AZEK Company
Conference presentation Investor relations Beat · Ultimate Achievement2 hits
08
The slide uses a dual-ring donut chart to represent revenue split by both business segment (Platform/Premium Games) and sales channel (Direct/Automated).Azerion | Investor Conference Presentation Deck | 31 slides · Azerion
Conference presentation Investor relations 2 hits
14
The slide uses a comparison frame to contrast casual vs premium game models.Azerion | Investor Conference Presentation Deck | 31 slides · Azerion
Conference presentation Investor relations Beat · ProductLoop · Mece Breakdown2 hits
21
The slide presents two distinct bar charts: one for operational performance (Avg. Gross Revenue per Million processed Ad Requests) and one for financial performance (Net Revenue and Adjusted EBITDA).Azerion | Investor Conference Presentation Deck | 31 slides · Azerion
Conference presentation Investor relations Beat · Financials2 hits
22
The slide uses a combination of a dual-axis combo chart for operational metrics and a grouped bar chart for financial performance.Azerion | Investor Conference Presentation Deck | 31 slides · Azerion
Conference presentation Investor relations Beat · Financials2 hits
09
Includes margin percentages overlaid on bar charts.Vivid Seats | Results Presentation Deck | 20 slides · Vivid Seats
Conference presentation Investor relations Beat · FinancialsLoop · So What Cascade2 hits
08
Includes revenue from DR.WU (mainland China), Galénic, Eve Lom, Abby's Choice, and others.Yatsen | Results Presentation Deck | 16 slides · Yatsen Holding Limited
Conference presentation Investor relations Loop · So What Cascade2 hits
12
Data shows a decline in revenue but an improvement in gross margin.Yatsen | Results Presentation Deck | 16 slides · Yatsen Holding Limited
Conference presentation Investor relations Beat · Visualization2 hits